NEW IMPROVED COMPOSITION CONTAINING AT LEAST ONE CADOTRIL Russian patent published in 2021 - IPC A61K31/223 A61K31/80 A61K47/10 A61K47/14 A61P1/00 A61P1/12 

Abstract RU 2751772 C2

FIELD: pharmaceuticals.

SUBSTANCE: invention relates to the field of pharmaceuticals and can be used for treatment of a subject suffering from a gastrointestinal disease or disorder. For this purpose, a semi-solid composition is proposed, containing at least one cadotril in an amount of 5% wt./ wt. to 50% wt./wt. and at least one excipient in form of a liquid lipid and/or propylene glycol in an amount from 20% wt./wt. to 90% wt./wt., wherein at least one cadotril crystallises forming small crystals and the excipient in form of a liquid lipid constitutes at least one medium chain triglyceride or at least an oil containing medium chain triglycerides or mixtures thereof. The semi-solid composition therein is in form of a tablet or capsule, is capable of supporting its own weight and retaining the shape, and is also capable to flow under pressure. The group of inventions also relates to a dosage unit containing said semi-solid composition, to an application of the composition for treatment of a subject suffering from a gastrointestinal disease or disorder, and to a method for treatment using the dosage unit.

EFFECT: group of inventions provides improved characteristics of absorption efficiency, bioavailability and/or controlled release such as extended or delayed release.

14 cl, 5 dwg, 6 tbl, 5 ex

Similar patents RU2751772C2

Title Year Author Number
NEW IMPROVED RACECADOTRIL COMPOSITION 2017
  • Muhammed, Salih Muhsin
  • Lindell, Katarina
RU2745888C2
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM CONTAINING HISTAMINE H2-RECEPTOR ANTAGONIST AND ANTACID 2017
  • Muhammed, Salih Muhsin
  • Lindell, Katarina
  • Siversson, Carina
RU2761346C2
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM 2019
  • Muhammed, Salih Muhsin
  • Lindell, Katarina
  • Nilgard, Jill
  • Nojd, Sofi
RU2810115C2
LIQUID ORAL PHARMACEUTICAL DOSAGE FORM 2019
  • Mukhammed, Salikh Mukhsin
  • Lindell, Katarina
  • Nilgard, Dzhill
  • Nejd, Sofi
RU2783413C2
RACECADOTRIL LIPID COMPOSITIONS 2014
  • Li Der-Yan
RU2662069C2
LIPID COMPOSITIONS OF RACECADOTRIL 2013
  • Li Der-Yan
RU2632441C2
PHARMACEUTICAL COMPOSITION OF 3α-ETHYNYL-3β-HYDROXYANDROSTAN-17-ONE OXIME 2018
  • Alhadeff, Paul
  • Doverskog, Magnus
  • Johansson, Maja
  • Meijer, Thomas
  • Schipper, Nicolaas
RU2779262C2
USE OF ORGANIC EXTRACT OF CITRUS FRUITS WITH HIGH ANTIMICROBIAL ACTIVITY AS SYSTEM OF PRESERVING AGENTS IN LIQUIDS, EMULSIONS, SUSPENSIONS, CREAMS AND ANTACIDS 2016
  • Barraza, Javier
  • Muniz, Renata
RU2714879C2
COMPOSITIONS CONTAINING UROLITINS 2016
  • Andre Penelopa
  • Rinsh Kristofer
  • Blanko-Boze Uilyam
RU2754761C2
PHARMACEUTICAL COMPOSITION OF TAXOIDS 2011
  • Khamar Bakulesh Mafatlal
  • Gogia Ashish Premkumar
  • Laddkhkha Ritu Nitin
  • Khan Imran Akhmed
  • Patravale Vandana Bkharat
  • Modi Indravadan Ambalal
RU2603833C2

RU 2 751 772 C2

Authors

Muhammed, Salih Muhsin

Lindell, Katarina

Hugerth, Andreas

Dates

2021-07-16Published

2017-01-09Filed